Browsing Clinical Studies by author "Koh, Dow-Mu"
Now showing items 1-1 of 1
-
Contrast-Enhanced CT Density Predicts Response to Sunitinib Therapy in Metastatic Renal Cell Carcinoma Patients.
Matoori, S; Thian, Y; Koh, D-M; Sohaib, A; Larkin, J; et al. (2017-08)The first-line therapy in metastatic renal cell carcinoma (mRCC), sunitinib, exhibits an objective response rate of approximately 30%. Therapeutic alternatives such as other tyrosine kinase inhibitors, VEGF inhibitors, or ...